Tekinalp, A. Et Al. 2023. Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4 , 242-250.

Tekinalp, A., GEDÜK, A., Akdeniz, A., Terzi Demirsoy, E., Gürsoy, V., Aslaner Ak, M., ... Bağcı, M.(2023). Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, 242-250.

Tekinalp, Atakan Et Al. "Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye," Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, 242-250, 2023

Tekinalp, Atakan Et Al. "Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, pp.242-250, 2023

Tekinalp, A. Et Al. (2023) . "Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.40, no.4, pp.242-250.

@article{article, author={Atakan Tekinalp Et Al. }, title={Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye}, journal={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year=2023, pages={242-250} }